Nadia Melanie Rupniak

Person

Bishops Stortford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Use of a NK-1 receptor antagonist and an antidepressant and/or an a...
- Patent number 6,649,614
- Issue date Nov 18, 2003
- Merck Sharp & Dohme Ltd.
- Emma Joanne Carlson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,613,765
- Issue date Sep 2, 2003
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating or preventing psychosomatic and psychoimmunolog...
- Patent number 6,573,261
- Issue date Jun 3, 2003
- Merck & Co., Inc.
- Nadia Rupniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of depression and anxiety with fluoxetine and an NK-1 rec...
- Patent number 6,319,953
- Issue date Nov 20, 2001
- Merck Sharp & Dohme Ltd.
- Emma Joanne Carlson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating cognitive disorders
- Patent number 6,271,230
- Issue date Aug 7, 2001
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating attention deficit disorder
- Patent number 6,242,446
- Issue date Jun 5, 2001
- Merck & Co., Inc.
- David L. Glatt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating or preventing psychosomatic and psychoimmunolog...
- Patent number 6,232,311
- Issue date May 15, 2001
- Merck & Co., Inc.
- Nadia Rupniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating movement disorders
- Patent number 6,156,749
- Issue date Dec 5, 2000
- Merck Sharp & Dohme Limited
- Nadia Melanie Rupniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating attention deficit disorder
- Patent number 6,121,261
- Issue date Sep 19, 2000
- Merck & Co., Inc.
- David L. Glatt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a NK-1 receptor antagonist and an antidepressant and/or an a...
- Patent number 6,117,855
- Issue date Sep 12, 2000
- Merck Sharp & Dohme Ltd.
- Emma Joanne Carlson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,114,315
- Issue date Sep 5, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptors antagonists for treating schizophrenic disorders
- Patent number 6,100,256
- Issue date Aug 8, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating amnestic disorders
- Patent number 6,096,729
- Issue date Aug 1, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating mania
- Patent number 6,090,819
- Issue date Jul 18, 2000
- Merck Sharp & Dohme, Ltd.
- Nadia Melanie Rupniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating stress disorders
- Patent number 6,087,348
- Issue date Jul 11, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,977,104
- Issue date Nov 2, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating or preventing psychoimmunological disorders
- Patent number 5,972,938
- Issue date Oct 26, 1999
- Merck & Co., Inc.
- Nadia Rupniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,952,315
- Issue date Sep 14, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating mania
- Patent number 5,952,330
- Issue date Sep 14, 1999
- Merck Sharp and Dohme Ltd.
- Nadia Melanie Rupniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating sexual dysfunctions
- Patent number 5,929,054
- Issue date Jul 27, 1999
- Merck Sharp
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating movement disorders
- Patent number 5,925,627
- Issue date Jul 20, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antogonists for treating substance use disorders
- Patent number 5,919,781
- Issue date Jul 6, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Method for treating premenstrual or late luteal phase syndrome
- Publication number 20020142942
- Publication date Oct 3, 2002
- Merck & Co. Inc.
- Bennett M. Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of a NK-1 receptor antagonist and an antidepressant and/or an a...
- Publication number 20020042361
- Publication date Apr 11, 2002
- Merck Sharp & Dohme Ltd.
- Emma Joanne Carlson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for treating or preventing psychosomatic and psychoimmunolog...
- Publication number 20010029244
- Publication date Oct 11, 2001
- MERCK & CO., Inc.
- Nadia Rupniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Nadia Melanie Rupniak

Person

Patents Grantslast 30 patents

Use of a NK-1 receptor antagonist and an antidepressant and/or an a...

Use of NK-1 receptor antagonists for treating major depressive diso...

Method for treating or preventing psychosomatic and psychoimmunolog...

Treatment of depression and anxiety with fluoxetine and an NK-1 rec...

Use of NK-1 receptor antagonists for treating cognitive disorders

Method for treating attention deficit disorder

Method for treating or preventing psychosomatic and psychoimmunolog...

Use of NK-1 receptor antagonists for treating movement disorders

Method for treating attention deficit disorder

Use of a NK-1 receptor antagonist and an antidepressant and/or an a...

Use of NK-1 receptor antagonists for treating major depressive diso...

Use of NK-1 receptors antagonists for treating schizophrenic disorders

Use of NK-1 receptor antagonists for treating amnestic disorders

Use of NK-1 receptor antagonists for treating mania

Use of NK-1 receptor antagonists for treating stress disorders

Use of NK-1 receptor antagonists for treating bipolar disorders

Method for treating or preventing psychoimmunological disorders

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating mania

Use of NK-1 receptor antagonists for treating sexual dysfunctions

Use of NK-1 receptor antagonists for treating movement disorders

Use of NK-1 receptor antogonists for treating substance use disorders

Patents Applicationslast 30 patents

Method for treating premenstrual or late luteal phase syndrome

Use of a NK-1 receptor antagonist and an antidepressant and/or an a...

Method for treating or preventing psychosomatic and psychoimmunolog...